{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:31:53Z","timestamp":1776310313808,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101095052"],"award-info":[{"award-number":["101095052"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101095052"],"award-info":[{"award-number":["101095052"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101095052"],"award-info":[{"award-number":["101095052"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101080711"],"award-info":[{"award-number":["101080711"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101095052"],"award-info":[{"award-number":["101095052"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101080711"],"award-info":[{"award-number":["101080711"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101095052"],"award-info":[{"award-number":["101095052"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09120012110075"],"award-info":[{"award-number":["09120012110075"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09120012110075"],"award-info":[{"award-number":["09120012110075"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09120012110075"],"award-info":[{"award-number":["09120012110075"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101071386"],"award-info":[{"award-number":["101071386"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101071386"],"award-info":[{"award-number":["101071386"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rheumatoid arthritis (RA) is a heterogeneous disease with variable symptoms, prognosis, and treatment response, necessitating refined patient classification. We applied multimodal deep learning and clustering to identify distinct RA phenotypes using baseline clinical data from 1,387 patients in the Leiden Rheumatology clinic. Four Joint Involvement Patterns (JIP) emerged: foot-predominant arthritis, seropositive oligoarticular disease, seronegative hand arthritis, and polyarthritis. Findings were validated in clinical trial data (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009307) and an independent secondary care cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009515). Clusters showed high stability and significant differences in remission rates (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.007) and methotrexate failure (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). JIP-hand patients had superior outcomes (particularly in ACPA-positive patients) versus JIP-foot (HR:0.37,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and JIP-poly (HR:0.33,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.005), independent of baseline disease activity and clinical markers. Synovial histology analysis (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009194) revealed distinct inflammatory patterns across clusters, hinting at different underlying biological mechanisms. These validated RA phenotypes based on joint involvement patterns may enable targeted research into disease mechanisms and personalized treatment strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41746-025-01997-1","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:39:02Z","timestamp":1761230342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets"],"prefix":"10.1038","volume":"8","author":[{"given":"Tjardo D.","family":"Maarseveen","sequence":"first","affiliation":[]},{"given":"Marc P.","family":"Maurits","sequence":"additional","affiliation":[]},{"given":"Lavinia Agra","family":"Coletto","sequence":"additional","affiliation":[]},{"given":"Simone","family":"Perniola","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"B\u00f6hringer","sequence":"additional","affiliation":[]},{"given":"Nils","family":"Steinz","sequence":"additional","affiliation":[]},{"given":"Sytske Anne","family":"Bergstra","sequence":"additional","affiliation":[]},{"given":"Dario","family":"Bruno","sequence":"additional","affiliation":[]},{"given":"Maria Rita","family":"Gigante","sequence":"additional","affiliation":[]},{"given":"Viviana A.","family":"Pacucci","sequence":"additional","affiliation":[]},{"given":"Luca","family":"Petricca","sequence":"additional","affiliation":[]},{"given":"Bianca","family":"Boxma-de Klerk","sequence":"additional","affiliation":[]},{"given":"Herman Kasper","family":"Glas","sequence":"additional","affiliation":[]},{"given":"Clara","family":"Di Mario","sequence":"additional","affiliation":[]},{"given":"Denise","family":"Campobasso","sequence":"additional","affiliation":[]},{"given":"Barbara","family":"Tolusso","sequence":"additional","affiliation":[]},{"given":"Josien","family":"Veris-van Dieren","sequence":"additional","affiliation":[]},{"given":"Annette H. M.","family":"van der Helm-van Mil","sequence":"additional","affiliation":[]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[]},{"given":"Maria Antonietta","family":"D\u2019Agostino","sequence":"additional","affiliation":[]},{"given":"Marcel J. T.","family":"Reinders","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Gessi","sequence":"additional","affiliation":[]},{"given":"Tom W. J.","family":"Huizinga","sequence":"additional","affiliation":[]},{"given":"Stefano","family":"Alivernini","sequence":"additional","affiliation":[]},{"given":"Erik B.","family":"van den Akker","sequence":"additional","affiliation":[]},{"given":"Rachel","family":"Knevel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"1997_CR1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0720-048X(98)00038-2","volume":"27","author":"W Grassi","year":"1998","unstructured":"Grassi, W. et al. The clinical features of rheumatoid arthritis. Eur. J. Radiol. 27, S18\u2013S24 (1998).","journal-title":"Eur. J. Radiol."},{"key":"1997_CR2","first-page":"161","volume":"2","author":"B Heidari","year":"2011","unstructured":"Heidari, B. Rheumatoid arthritis: early diagnosis and treatment outcomes. Casp. J. Intern. Med. 2, 161\u2013170 (2011).","journal-title":"Casp. J. Intern. Med."},{"key":"1997_CR3","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.41726","volume":"73","author":"S Alivernini","year":"2021","unstructured":"Alivernini, S. et al. Inclusion of synovial tissue-derived characteristics in a nomogram for the prediction of treatment response in treatment-naive rheumatoid arthritis patients. Arthritis Rheumatol. 73, 1601\u20131613 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1997_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-022-00912-0","volume":"44","author":"L Padyukov","year":"2022","unstructured":"Padyukov, L. Genetics of rheumatoid arthritis. Semin. Immunopathol. 44, 47\u201362 (2022).","journal-title":"Semin. Immunopathol."},{"key":"1997_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/ard.2009.113092","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen, S. W. et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10\u2009year prospective study. Ann. Rheum. Dis. 69, 345\u2013351 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR6","doi-asserted-by":"publisher","first-page":"e1003296","DOI":"10.1371\/journal.pmed.1003296","volume":"17","author":"XME Matthijssen","year":"2020","unstructured":"Matthijssen, X. M. E. et al. Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25\u2009years: a longitudinal cohort study in the Netherlands. PLoS Med. 17, e1003296 (2020).","journal-title":"PLoS Med."},{"key":"1997_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/ar2022","volume":"8","author":"M Pedersen","year":"2006","unstructured":"Pedersen, M. et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res. Ther. 8, R133 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"1997_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","volume":"76","author":"LB Nordberg","year":"2017","unstructured":"Nordberg, L. B. et al. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-na\u00efve patients classified according to the 2010 ACR\/EULAR criteria. Ann. Rheum. Dis. 76, 341\u2013345 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40266-015-0341-2","volume":"33","author":"T Sugihara","year":"2016","unstructured":"Sugihara, T. & Harigai, M. Targeting low disease activity in elderly-onset rheumatoid arthritis: current and future roles of biological disease-modifying antirheumatic drugs. Drugs Aging 33, 97\u2013107 (2016).","journal-title":"Drugs Aging"},{"key":"1997_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/art.1780280905","volume":"28","author":"CL Deal","year":"1985","unstructured":"Deal, C. L. et al. The clinical features of elderly-onset rheumatoid arthritis: a comparison with younger-onset disease of similar duration. Arthritis Rheum. 28, 987\u2013994 (1985).","journal-title":"Arthritis Rheum."},{"key":"1997_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361\u2013369 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1997_CR12","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2014.02.006","volume":"133","author":"JA Howrylak","year":"2014","unstructured":"Howrylak, J. A. et al. Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J. Allergy Clin. Immunol. 133, 1289\u20131300 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1997_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/annrheumdis-2021-221763","volume":"81","author":"F Angelini","year":"2022","unstructured":"Angelini, F. et al. Osteoarthritis endotype discovery via clustering of biochemical marker data. Ann. Rheum. Dis. 81, 666\u2013675 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR14","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","volume":"28","author":"MJ Lewis","year":"2019","unstructured":"Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455\u20132470.e5 (2019).","journal-title":"Cell Rep."},{"key":"1997_CR15","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/annrheumdis-2019-215751","volume":"78","author":"G Lliso-Ribera","year":"2019","unstructured":"Lliso-Ribera, G. et al. Synovial tissue signatures enhance clinical classification and prognostic\/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC). Ann. Rheum. Dis. 78, 1642\u20131652 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.55563\/clinexprheumatol\/24zas6","volume":"39","author":"SM Jung","year":"2021","unstructured":"Jung, S. M., Park, K. S. & Kim, K. J. Clinical phenotype with high risk for initiation of biologic therapy in rheumatoid arthritis: a data-driven cluster analysis. Clin. Exp. Rheumatol. 39, 1282\u20131290 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1997_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/acr.24471","volume":"73","author":"JR Curtis","year":"2021","unstructured":"Curtis, J. R. et al. Data-driven patient clustering and differential clinical outcomes in the brigham and women\u2019s rheumatoid arthritis sequential study registry. Arthritis Care Res. (Hoboken) 73, 471\u2013480 (2021).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"1997_CR18","doi-asserted-by":"publisher","first-page":"e000656","DOI":"10.1136\/rmdopen-2018-000656","volume":"4","author":"JF Merola","year":"2018","unstructured":"Merola, J. F., Espinoza, L. R. & Fleischmann, R. Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open 4, e000656 (2018).","journal-title":"RMD Open"},{"key":"1997_CR19","doi-asserted-by":"publisher","unstructured":"Onken, A., Yague, J. G. & Sakata, S. Deep multimodal autoencoders for identifying latent representations of spike counts and local field potentials. Bernstein Conf. https:\/\/doi.org\/10.12751\/nncn.bc2018.0223 (2018).","DOI":"10.12751\/nncn.bc2018.0223"},{"key":"1997_CR20","doi-asserted-by":"crossref","unstructured":"Steinbach, M., Ert\u00f6z, L. & Kumar, V. The challenges of clustering high-dimensional data. In New Directions in Statistical Physics: Econophysics, Bioinformatics, and Pattern Recognition (ed. Wille, L. T.) 273\u2013309 (Springer, Berlin, 2004).","DOI":"10.1007\/978-3-662-08968-2_16"},{"key":"1997_CR21","doi-asserted-by":"crossref","unstructured":"Cai, J. et al. Efficient deep embedded subspace clustering. In Proc. IEEE\/CVF Conf. Comput. Vis. Pattern Recognit. 1\u201310 (IEEE, 2022).","DOI":"10.1109\/CVPR52688.2022.00012"},{"key":"1997_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91297-x","volume":"11","author":"J Castela Forte","year":"2021","unstructured":"Castela Forte, J. et al. Identifying and characterizing high-risk clusters in a heterogeneous ICU population with deep embedded clustering. Sci. Rep. 11, 12109 (2021).","journal-title":"Sci. Rep."},{"key":"1997_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura, K. et al. Meta-analysis: diagnostic accuracy of anti\u2013cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann. Intern. Med. 146, 797\u2013808 (2007).","journal-title":"Ann. Intern. Med."},{"key":"1997_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/annrheumdis-2014-206047","volume":"74","author":"JAB van Nies","year":"2015","unstructured":"van Nies, J. A. B. et al. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann. Rheum. Dis. 74, 806\u2013812 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser, H. et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 46, 357\u2013365 (2002).","journal-title":"Arthritis Rheum."},{"key":"1997_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358\u2013364 (2006).","journal-title":"Histopathology"},{"key":"1997_CR27","doi-asserted-by":"crossref","unstructured":"Ciurea, A., Ospelt, C. Location-specific treatment of chronic inflammatory joint disease. Nat. Rev. Rheumatol. 21, 507\u2013508 (2025)","DOI":"10.1038\/s41584-025-01278-x"},{"key":"1997_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-019-2773-z","volume":"20","author":"SW Lee","year":"2019","unstructured":"Lee, S. W. et al. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study. BMC Musculoskelet. Disord. 20, 420 (2019).","journal-title":"BMC Musculoskelet. Disord."},{"key":"1997_CR29","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00296-022-05147-8","volume":"42","author":"A Hoque","year":"2022","unstructured":"Hoque, A., Steultjens, M., Dickson, D. M. & Hendry, G. J. Patients\u2019 and clinicians\u2019 perspectives on the clinical utility of the rheumatoid arthritis foot disease activity index. Rheumatol. Int. 42, 1807\u20131817 (2022).","journal-title":"Rheumatol. Int."},{"key":"1997_CR30","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/art.33506","volume":"64","author":"MD Wechalekar","year":"2012","unstructured":"Wechalekar, M. D. et al. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis Rheum. 64, 1316\u20131322 (2012).","journal-title":"Arthritis Rheum."},{"key":"1997_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13075-023-03144-1","volume":"25","author":"A Ciurea","year":"2023","unstructured":"Ciurea, A. et al. Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start. Arthritis Res. Ther. 25, 185 (2023).","journal-title":"Arthritis Res. Ther."},{"key":"1997_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11849","volume":"7","author":"R Ai","year":"2016","unstructured":"Ai, R. et al. Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes. Nat. Commun. 7, 11849 (2016).","journal-title":"Nat. Commun."},{"key":"1997_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41584-020-00570-2","volume":"17","author":"CD Buckley","year":"2021","unstructured":"Buckley, C. D. et al. Location, location, location: how the tissue microenvironment affects inflammation in RA. Nat. Rev. Rheumatol. 17, 195\u2013212 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1997_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14852","volume":"8","author":"M Frank-Bertoncelj","year":"2017","unstructured":"Frank-Bertoncelj, M. et al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat. Commun. 8, 14852 (2017).","journal-title":"Nat. Commun."},{"key":"1997_CR35","doi-asserted-by":"publisher","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AHM van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil, A. H. M. et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res. Ther. 7, R949\u2013R958 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"1997_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fmed.2018.00339","volume":"5","author":"S Bugatti","year":"2018","unstructured":"Bugatti, S. et al. The clinical value of autoantibodies in rheumatoid arthritis. Front. Med. (Lausanne) 5, 339 (2018).","journal-title":"Front. Med. (Lausanne)"},{"key":"1997_CR37","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"1997_CR38","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1136\/annrheumdis-2017-211325","volume":"76","author":"LE Burgers","year":"2017","unstructured":"Burgers, L. E. et al. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis. Ann. Rheum. Dis. 76, 1751\u20131754 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2022","unstructured":"Sokolova, M. V., Schett, G. & Steffen, U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin. Rev. Allergy Immunol. 63, 138\u2013151 (2022).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"1997_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-022-02851-5","volume":"24","author":"SQ Duong","year":"2022","unstructured":"Duong, S. Q. et al. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data. Arthritis Res. Ther. 24, 162 (2022).","journal-title":"Arthritis Res. Ther."},{"key":"1997_CR41","doi-asserted-by":"publisher","first-page":"e000752","DOI":"10.1136\/rmdopen-2018-000752","volume":"4","author":"LB Nordberg","year":"2018","unstructured":"Nordberg, L. B. et al. Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR\/EULAR classification criteria in a treat-to-target setting: 2\u2009year data from the ARCTIC trial. RMD Open 4, e000752 (2018).","journal-title":"RMD Open"},{"key":"1997_CR42","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/art.1780330901","volume":"33","author":"SJ Naides","year":"1990","unstructured":"Naides, S. J. et al. Rheumatologic manifestations of human parvovirus B19 infection in adults: initial two-year clinical experience. Arthritis Rheum. 33, 1297\u20131309 (1990).","journal-title":"Arthritis Rheum."},{"key":"1997_CR43","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.1073\/pnas.95.14.8227","volume":"95","author":"Y Takahashi","year":"1998","unstructured":"Takahashi, Y. et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 95, 8227\u20138232 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1997_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.42.6.605","volume":"42","author":"TM Burns","year":"1983","unstructured":"Burns, T. M. & Calin, A. The hand radiograph as a diagnostic discriminant between seropositive and seronegative \u2018rheumatoid arthritis\u2019: a controlled study. Ann. Rheum. Dis. 42, 605\u2013612 (1983).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR45","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-022-01789-0","volume":"28","author":"F Rivellese","year":"2022","unstructured":"Rivellese, F. et al. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. Nat. Med. 28, 1256\u20131268 (2022).","journal-title":"Nat. Med."},{"key":"1997_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/annrheumdis-2021-220882","volume":"81","author":"SL Heckert","year":"2022","unstructured":"Heckert, S. L. et al. Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease course. Ann. Rheum. Dis. 81, 169\u2013174 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR47","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1093\/rheumatology\/ker294","volume":"50","author":"JF Baker","year":"2011","unstructured":"Baker, J. F. et al. Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Rheumatology 50, 2100\u20132107 (2011).","journal-title":"Rheumatology"},{"key":"1997_CR48","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/acr.23229","volume":"69","author":"MD George","year":"2017","unstructured":"George, M. D. et al. Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res. 69, 1789\u20131798 (2017).","journal-title":"Arthritis Care Res."},{"key":"1997_CR49","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/sj.ijo.0800770","volume":"22","author":"V Mohamed-Ali","year":"1998","unstructured":"Mohamed-Ali, V., Pinkney, J. H. & Coppack, S. W. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord. 22, 1145\u20131158 (1998).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"1997_CR50","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","volume":"282","author":"M Visser","year":"1999","unstructured":"Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H. & Harris, T. B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131\u20132135 (1999).","journal-title":"JAMA"},{"key":"1997_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1406-7","volume":"18","author":"EM Bauer","year":"2017","unstructured":"Bauer, E. M. et al. Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients. BMC Musculoskelet. Disord. 18, 99 (2017).","journal-title":"BMC Musculoskelet. Disord."},{"key":"1997_CR52","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"1997_CR53","doi-asserted-by":"publisher","first-page":"e23930","DOI":"10.2196\/23930","volume":"8","author":"TD Maarseveen","year":"2020","unstructured":"Maarseveen, T. D. et al. Machine learning electronic health record identification of patients with rheumatoid arthritis: algorithm pipeline development and validation study. JMIR Med. Inform. 8, e23930 (2020).","journal-title":"JMIR Med. Inform."},{"key":"1997_CR54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-021-02553-4","volume":"23","author":"TD Maarseveen","year":"2021","unstructured":"Maarseveen, T. D. et al. Handwork vs machine: a comparison of rheumatoid arthritis patient populations as identified from EHR free-text by diagnosis extraction through machine-learning or traditional criteria-based chart review. Arthritis Res. Ther. 23, 174 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"1997_CR55","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/annrheumdis-2013-203243","volume":"73","author":"L Heimans","year":"2014","unstructured":"Heimans, L. et al. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study. Ann. Rheum. Dis. 73, 1356\u20131361 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1997_CR56","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184\u2013197 (2015).","journal-title":"Cell"},{"key":"1997_CR57","doi-asserted-by":"crossref","unstructured":"Roth, A. E. The Shapley Value: Essays in Honor of Lloyd S. Shapley (Cambridge Univ. Press, 1988).","DOI":"10.1017\/CBO9780511528446"},{"key":"1997_CR58","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"1997_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. Ser. B 34, 187\u2013202 (1972).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"1997_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/biomet\/67.1.145","volume":"67","author":"D Schoenfeld","year":"1980","unstructured":"Schoenfeld, D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 67, 145\u2013153 (1980).","journal-title":"Biometrika"},{"key":"1997_CR61","unstructured":"Maarseveen, T. D. EHR Clustering RA. https:\/\/github.com\/levrex\/EHR-Clustering-RA (2022)."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01997-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:03:11Z","timestamp":1761235391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01997-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6256181\/v1","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"623"}}